S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Details
Age
Adult
Locations
Rocky Mountain Regional VA Medical Center
Principal Investigator
Jessica McDermott
Study ID
Protocol Number: 21-2852
More information available at ClinicalTrials.gov: NCT04214262
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers